AIA Introduces Bold Changes To New Zealand Health Insurance Market
- Written by iPMI Magazine
- font size decrease font size increase font size
AIA signaled its growth intentions with enhancements to its personal product range, and launching with a new health product that lifts medical cover to $500,000, with a discount regime to make their insurance products more affordable for customers.
The new Real Health product introduces new $500,000 limits on surgical and non-surgical treatments, including new generation, non-Pharmac treatments for cancer, such as the innovative immunotherapy treatments, that are otherwise unaffordable for the average New Zealander.
Chief Executive Natalie Cameron says, “Our new Real Health policy directly addresses the affordability issues for these new treatments, but we’re also moving to address the general affordability of insurance cover for the average New Zealander by introducing a generous discount regime on premiums.”
AIA customers who purchase the Real Life policy together with other insurance policies receive an escalating discount per extra policy.
“The more policies that are bundled up, the greater the discount that is available,” Cameron says.
The two initiatives, taken together, will increase the number of New Zealanders gaining access to the latest life-saving drugs and treatments, she added.
“These new drugs and treatments are coming to market quickly and although there is uncertainty around when and how much they will cost, we can be sure that costs will continue to rise,” comments Cameron. “The insurance industry is about effectively managing risk and we are introducing this new product now in the expectation that New Zealanders will need that level of support in the near future.”
- APRIL International Care Announces Enhancements To MyHEALTH Hong Kong Private International Health Insurance Policy Range
- Broadstone Group Enters IPMI Market With Acquisition Of Specialist IPMI and Employee Benefits Firm
- Employers Need To Consider Wellbeing Of Overseas Employees’ Dependants
- Bupa Appoints New Head Of SME Intermediary Development
- nib Responds To The Australian Competition and Consumer Commission (ACCC)
- Cigna Reports Third Quarter 2016 Results Led By Strong Commercial Health Care Performance
- Medical Treatment Costs In Asia September 2016
- Aetna International Declared Runner-Up In ‘Employee Benefits Services Provider Of The Year’ Award
- Munich Re Appoints Tom Warnes Chief Clinical and Operating Officer of Munich Health North America
- Latinos And People With Low Incomes Are Most Likely To Be Uninsured
Latest from iPMI Magazine
- iPMI Magazine Speaks With Eithan Wolf, CEO, PassportCard Germany
- HCI Group Launches New Modular iPMI Plan, NIMBL Health
- APRIL International Maintains Top IPMI Service Rating For 2nd Consecutive Year
- Allianz Partners Continues Growth Trajectory Driven By Travel Rebound
- Allianz Partners Enhances Health Business With New Appointments